Drug intelligence / Profile preview

collagen + povidone

Development stage: Phase 4
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Collagen + povidone is a combination product used for wound healing and infection prevention. Collagen provides structural support for tissue regeneration and promotes epithelialization, while povidone (often used as povidone-iodine) offers antiseptic properties. This combination likely enhances wound healing by providing both a scaffold for tissue repair and antimicrobial protection.

Brand names: Fibroquel
Other names: polyvidone + collagen

Targets

DDR1/2 (Discoidin domain-containing receptor 1 (DDR1) and Discoidin domain-containing receptor 2 (DDR2))Neuraminidase

Beyond the preview

Go deeper on collagen + povidone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on collagen + povidone.

Explore the full profile